Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Construction in Progress (2020 - 2025)

Historic Construction in Progress for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $685000.0.

  • Insight Molecular Diagnostics' Construction in Progress rose 12682.12% to $685000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $685000.0, marking a year-over-year increase of 12682.12%. This contributed to the annual value of $340000.0 for FY2024, which is 5316.8% down from last year.
  • Insight Molecular Diagnostics' Construction in Progress amounted to $685000.0 in Q3 2025, which was up 12682.12% from $263000.0 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Construction in Progress registered a high of $3.1 million during Q1 2022, and its lowest value of $263000.0 during Q2 2025.
  • Moreover, its 5-year median value for Construction in Progress was $685000.0 (2025), whereas its average is $1.1 million.
  • In the last 5 years, Insight Molecular Diagnostics' Construction in Progress plummeted by 8582.79% in 2021 and then skyrocketed by 73052.33% in 2022.
  • Over the past 5 years, Insight Molecular Diagnostics' Construction in Progress (Quarter) stood at $1.2 million in 2021, then skyrocketed by 72.3% to $2.1 million in 2022, then plummeted by 66.07% to $726000.0 in 2023, then crashed by 53.17% to $340000.0 in 2024, then surged by 101.47% to $685000.0 in 2025.
  • Its last three reported values are $685000.0 in Q3 2025, $263000.0 for Q2 2025, and $360000.0 during Q1 2025.